Enhanced immunity against SARS-CoV-2 in returning Chinese individuals

Author:

Yuan Runyu1,Chen Huimin12,Yi Lina1,Li Xinxin12,Hu Ximing13,Li Xing1,Zhang Huan1,Zhou Pingping1,Liang Chumin1,Lin Huifang1,Zeng Lilian1,Zhuang Xue1,Ruan QianQian14,Chen Yueling15,Deng Yingyin13,Liu Zhe1,Lu Jing1,Xiao Jianpeng1,Chen Liang1,Xiao Xincai6,Li Jing7,Li Baisheng1,Li Yan1,He Jianfeng1,Sun Jiufeng12345ORCID

Affiliation:

1. Guangdong Workstation for Emerging Infectious Disease Control and Prevention, Guangdong Provincial Key Laboratory of Pathogen Detection for Emerging Infectious Disease Response, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China

2. Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China

3. School of Public Health, Southern Medical University, Guangzhou, China

4. School of Public Health, Sun Yat-Sen University, Guangzhou, China

5. School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China

6. Guangzhou Chest Hospital, Guangzhou Medical University, Guangzhou, China

7. Quality Control Department, Sinovac Life Sciences Co. Ltd., Beijing, China

Funder

the Guangdong Science and Technology Program

Publisher

Informa UK Limited

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3